MPISX
Price
$6.70
Change
-$0.18 (-2.62%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

MPISX vs RMFCX

Header iconMPISX vs RMFCX Comparison
Open Charts MPISX vs RMFCXBanner chart's image
BNY Mellon Income Stock M
Price$6.70
Change-$0.18 (-2.62%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
MPISX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MPISX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MPISX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. MPISX (189M). MPISX pays higher dividends than RMFCX: MPISX (1.92) vs RMFCX (1.69). MPISX was incepted earlier than RMFCX: MPISX (24 years) vs RMFCX (23 years). MPISX is a more actively managed with annual turnover of: 83.54 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than MPISX: RMFCX (250) vs MPISX (10000). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. MPISX (-2.59). RMFCX return over 5 years is better than : 40.39 vs. MPISX (-15.56).
MPISXRMFCXMPISX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years23 years-
Gain YTD-3.39411.423-30%
Front LoadN/AN/A-
Min. Initial Investment100002504,000%
Min. Initial Investment IRAN/AN/A-
Net Assets189M98.7B0%
Annual Yield % from dividends1.921.69114%
Returns for 1 year-2.5912.63-20%
Returns for 3 years-19.0514.16-135%
Returns for 5 years-15.5640.39-39%
Returns for 10 years-14.1961.84-23%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc